We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
SPX Corp
SPXC
$10.8B
| $14M | 0.03% |
+274,632
| New | +$12.6M |
|
502
F5
FFIV
$22.7B
| $13.9M | 0.03% |
99,419
-80,181
| -45% | -$11.3M |
|
503
NovoCure
NVCR
$1.91B
| $13.8M | 0.03% |
+164,205
| New | +$13.3M |
|
|
AVP
504
DELISTED
Avon Products, Inc.
AVP
| $13.8M | 0.03% |
2,448,155
+754,250
| +45% | +$3.5M |
|
|
QEP
505
DELISTED
QEP RESOURCES, INC.
QEP
| $13.8M | 0.03% |
3,066,836
+1,562,033
| +104% | +$5.44M |
|
506
Innospec
IOSP
$2.28B
| $13.8M | 0.03% |
133,185
+104,559
| +365% | +$10M |
|
|
GES
507
DELISTED
Guess Inc
GES
| $13.8M | 0.03% |
615,017
+381,295
| +163% | +$7.11M |
|
508
TechnipFMC
FTI
$27.3B
| $13.7M | 0.03% |
865,084
+781,890
| +940% | +$12.1M |
|
509
Installed Building Products
IBP
$6.49B
| $13.7M | 0.03% |
198,858
+64,544
| +48% | +$4.35M |
|
510
Textron
TXT
$15.4B
| $13.6M | 0.03% |
305,598
-508,954
| -62% | -$23.6M |
|
511
Bread Financial
BFH
$4.38B
| $13.6M | 0.03% |
151,783
+94,809
| +166% | +$8.37M |
|
|
SRCI
512
DELISTED
SRC Energy Inc
SRCI
| $13.6M | 0.03% |
3,296,963
+1,562,460
| +90% | +$5.93M |
|
|
EV
513
DELISTED
Eaton Vance Corp.
EV
| $13.5M | 0.03% |
289,162
+235,662
| +440% | +$10.9M |
|
|
PSXP
514
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $13.5M | 0.03% |
218,404
+195,598
| +858% | +$11M |
|
515
StoneCo
STNE
$2.58B
| $13.4M | 0.03% |
336,303
+328,503
| +4,212% | +$12M |
|
|
PDCO
516
DELISTED
Patterson Companies, Inc.
PDCO
| $13.4M | 0.03% |
655,011
+250,254
| +62% | +$4.74M |
|
517
Cimpress
CMPR
$2.31B
| $13.4M | 0.03% |
+106,208
| New | +$13.8M |
|
518
B&G Foods
BGS
$286M
| $13.2M | 0.03% |
737,506
-322,183
| -30% | -$5.42M |
|
519
Devon Energy
DVN
$47.3B
| $13.2M | 0.03% |
508,803
+130,153
| +34% | +$2.93M |
|
|
SF
520
Stifel
SF
$12.6B
| $13.2M | 0.03% |
488,135
+184,135
| +61% | +$4.81M |
|
521
Paylocity
PCTY
$7.98B
| $13.1M | 0.03% |
108,255
+7,655
| +8% | +$838K |
|
522
Equitable Holdings
EQH
$14.1B
| $13.1M | 0.03% |
527,546
-767,229
| -59% | -$17.8M |
|
523
Patrick Industries
PATK
$2.85B
| $13M | 0.03% |
372,885
+64,551
| +21% | +$2.1M |
|
|
X
524
DELISTED
US Steel
X
| $13M | 0.03% |
+1,139,800
| New | +$14.1M |
|
|
GWB
525
DELISTED
Great Western Bancorp, Inc.
GWB
| $13M | 0.03% |
373,832
+107,595
| +40% | +$3.72M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.